DOCSLIB.ORG

Improvement of Testicular Steroidogenesis Using Flavonoids and Isoflavonoids for Prevention of Late-Onset Male Hypogonadism

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Improvement of Testicular Steroidogenesis Using Flavonoids and Isoflavonoids for Prevention of Late-Onset Male Hypogonadism antioxidants Review Improvement of Testicular Steroidogenesis Using Flavonoids and Isoflavonoids for Prevention of Late-Onset Male Hypogonadism Luc J. Martin 1,* and Mohamed Touaibia 2 1 Biology Department, Université de Moncton, Moncton, NB E1A 3E9, Canada 2 Chemistry and Biochemistry Department, Université de Moncton, Moncton, NB E1A 3E9, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-506-858-4938 Received: 19 February 2020; Accepted: 10 March 2020; Published: 13 March 2020 Abstract: Androgen production, being important for male fertility, is mainly accomplished by the Leydig cells from the interstitial compartment of the testis. Testosterone plays a critical role in testis development, normal masculinization, and the maintenance of spermatogenesis. Within seminiferous tubules, appropriate Sertoli cell function is highly dependent on testicular androgen levels and is essential to initiate and maintain spermatogenesis. During aging, testosterone production by the testicular Leydig cells declines from the 30s in humans at a rate of 1% per year. This review outlines the recent findings regarding the use of flavonoids and isoflavonoids to improve testosterone production, contributing to normal spermatogenesis and preventing age-related degenerative diseases associated with testosterone deficiency. With the cumulation of information on the actions of different flavonoids and isoflavonoids on steroidogenesis in Leydig cells, we can now draw conclusions regarding the structure-activity relationship on androgen production. Indeed, flavonoids having a 5,7-dihydroxychromen-4-one backbone tend to increase the expression of the steroidogenic acute regulatory protein (StAR), being critical for the entry of cholesterol into the mitochondria, leading to increased testosterone production from testis Leydig cells. Therefore, flavonoids and isoflavonoids such as chrysin, apigenin, luteolin, quercetin, and daidzein may be effective in delaying the initiation of late-onset hypogonadism associated with aging in males. Keywords: testis; testosterone; androgen; Leydig cells; polyphenols; flavonoids 1. Introduction Testicular Leydig cells are the main site of androgen synthesis in mammals. Androgens are responsible for the development and maintenance of male sex organs and secondary sex characteristics. Specifically, embryonic testosterone is involved in the development of Wolffian ducts, leading to the formation of the epididymis, vas deferens, and seminal vesicles. In addition, testosterone is indirectly involved in the development of the genital tubercle to form the penis, scrotum, and prostate by its conversion to 5 α-dihydrotestosterone (DHT), the most potent androgen of the body. At puberty, testosterone plays a major role in masculinization of the brain, development of male sexual behavior, initiation and support of spermatogenesis, bone growth, maturation of the external genitalia, hair growth, and regulation of gonadotropins (luteinizing hormone (LH) and follicle-stimulating hormone (FSH)) secretion. Within the seminiferous tubules, Sertoli cells are stimulated by androgen through the expression of the androgen-binding protein (ABP, SHBG). In turn, activated Sertoli cells support germ cell division and normal spermatogenesis to maintain fertility. With aging, testosterone production declines, beginning in the 30s in men, at a rate of 1% per year [1]. Different conditions, such as exposure Antioxidants 2020, 9, 237; doi:10.3390/antiox9030237 www.mdpi.com/journal/antioxidants Antioxidants 2020, 9, 237 2 of 17 Antioxidants 2020, 9, 237 2 of 17 to endocrineyear [1]. Different disruptors, conditions, obesity, such diabetes as exposure and cancer to endocrine treatments, disruptors, exacerbate obesity, this diabetes decrease and in cancer serum testosteronetreatments, levels, exacerbate leading this to decrease the development in serum testosterone of late-onset levels, hypogonadism leading to [the2]. Age-relateddevelopment functional of late‐ alterationsonset hypogonadism include decreased [2]. Age response‐related functional of testicular alterations Leydig include cells to decreased the pituitary response LH [3 ].of Intesticular addition, middle-agedLeydig cells men to the have pituitary an increased LH [3]. prevalence In addition, of middle obesity‐aged and men insulin have resistance an increased associated prevalence with of low obesity and insulin resistance associated with low serum total testosterone and SHBG levels [4]. These serum total testosterone and SHBG levels [4]. These men are mainly responsible for the increase in men are mainly responsible for the increase in testosterone‐replacement therapies over the last testosterone-replacement therapies over the last decade [5]. Men with androgen deficiency may present decade [5]. Men with androgen deficiency may present with decreased libido, erectile dysfunction, with decreased libido, erectile dysfunction, decreased body hair, increased fatigue, decreased muscle decreased body hair, increased fatigue, decreased muscle mass and strength, increased body fat, low mass and strength, increased body fat, low bone mineral density, irritability, inability to concentrate, bone mineral density, irritability, inability to concentrate, and poor quality of life [6,7]. Therefore, andtherapies poor quality aiming of to life increase [6,7]. Therefore, serum levels therapies of testosterone aiming to may increase contribute serum to levels relieving of testosterone part of these may contributesymptoms to and relieving may involve part of nutritional these symptoms supplementation and may with involve flavonoids. nutritional In this supplementation review, a structure with‐ flavonoids.activity relationship In this review, for aplant structure-activity polyphenols with relationship flavonoid for backbone plant polyphenols on testosterone with flavonoid production backbone will onbe testosterone investigated production to draw conclusions will be investigated from cumulated to draw literature conclusions thus from far. cumulated literature thus far. 2. Steroidogenesis2. Steroidogenesis WithinWithin the the testis, testis, androgen androgen production, production, of which of which testosterone testosterone is the is mostthe most abundant, abundant, occurs occurs almost exclusivelyalmost exclusively in Leydig in cells. Leydig Androstenedione cells. Androstenedione and dehydroepiandrosterone and dehydroepiandrosterone (DHEA) (DHEA) are also are produced also byproduced the testis. by However, the testis. theirHowever, levels their of androgenicitylevels of androgenicity are lower are than lower those than ofthose testosterone. of testosterone. Adult LeydigAdult cells Leydig do express cells do the express aromatase the aromatase enzyme (CYP19A1) enzyme (CYP19A1) which is responsible which is responsible for the conversion for the of androgenconversion into of estrogen androgen [8]. into However, estrogen this [8]. rate However, of conversion this rate of testosterone of conversion into of estradiol testosterone is minimal into comparedestradiol to is the minimal secretion compared levels ofto androgen,the secretion and levels estrogen of androgen, may instead and estrogen play a bu mayffering instead action play on a the steroidogenesisbuffering action by on Leydig the steroidogenesis cells [9]. by Leydig cells [9]. TestosteroneTestosterone synthesis synthesis from from cholesterol cholesterol involves involves the sequential the sequential action action of several of several steroidogenic steroidogenic enzymes suchenzymes as the cholesterol such as the side-chain cholesterol cleavage side‐ enzymechain cleavage (CYP11A1), enzyme cytochrome (CYP11A1), P450 17cytochromeα-hydroxylase P450/20-lyase 17α‐ (CYP17A1),hydroxylase/20 3β-hydroxysteroid‐lyase (CYP17A1), dehydrogenase 3β‐hydroxysteroid (HSD3B1 dehydrogenase in rodents and (HSD3B1 HSD3B2 in in rodents humans), and and 17βHSD3B2-hydroxysteroid in humans), dehydrogenase and 17β‐hydroxysteroid type 3 (HSD17B3), dehydrogenase catalyzing type a 3 cascade (HSD17B3), of hydroxylation, catalyzing a cascadecleavage, dehydrogenation,of hydroxylation, and cleavage, isomerization dehydrogenation, reactions. and Testosterone isomerization synthesis reactions. from Testosterone cholesterol synthesis and its from cholesterol and its conversion to other estrogenic and androgenic active metabolites is presented conversion to other estrogenic and androgenic active metabolites is presented in Figure1. in Figure 1. Figure 1. Common pathways for steroid synthesis within Leydig cells. Abbreviations for enzymes: Cyp11a1,Figure 1. P450 Common side-chain pathways cleavage; for steroid Hsd3b1, synthesis 3β-hydroxysteroid within Leydig cells. dehydrogenase; Abbreviations Cyp17a1,for enzymes: P450 17αCyp11a1,-hydroxylase P450/ 20-lyase;side‐chain Hsd17b3, cleavage; 17 Hsd3b1,β-hydroxysteroid 3β‐hydroxysteroid dehydrogenase; dehydrogenase; Srd5a1, 5 αCyp17a1,-reductase; P450 Cyp19a1, 17α‐ P450 aromatase. Abbreviations for steroids: DHEA, dehydroepiandrosterone; DHT, dihydrotestosterone. Antioxidants 2020, 9, 237 3 of 17 In Leydig cells, as in other steroidogenic tissues, cholesterol is the primary substrate for steroid synthesis. Cholesterol may be synthesized from acetyl-coenzyme A or derived from plasma reserves through the receptor-mediated endocytosis of low-density lipoprotein (LDL) particles. In each case, cholesterol is stored in esterified form in cytoplasmic lipid droplets. The contribution of the two sources of cholesterol for steroidogenesis
Load more

Recommended publications
  • Estroquench™ Hormone Specific Formulation™
    PRODUCT DATA DOUGLAS LABORATORIES® 08/2014 1 EstroQuench™ Hormone Specific Formulation™ DESCRIPTION EstroQuench™ is a Hormone Specific Formulation™ of ingredients that have documented anti-aromatase activity as well as androgenic adaptogens which support the function of endogenous aromatase inhibitors. Collectively these herbs promote minimal production and function of estrogens, while promoting testosterone function, including optimal sexual function in both genders. This formulation is designed to quench excessive production of estrogens and aberrant functions of them while supporting optimal function of androgens by maintaining the health of androgen producing glands.† Hormone Specific Formulation™ provided by Douglas Laboratories® and formulated by Dr. Joseph J Collins is created to support the optimal function of specific hormones through the use of hormone specific adaptogens, hormone specific agonists and hormone specific functional mimetics. This formulation may be used as part of a hormone health program with dietary and nutrient support. In addition, this formulation may be used by clinicians as an adjuvant to support optimal hormone health in patients who have been prescribed bioidentical hormone therapies. FUNCTIONS Aromatase (a cytochrome P450 enzyme {CYP19}) is the enzyme that controls the conversion of androgens to estrogens. More specifically, aromatase is the enzyme responsible for catalyzing the biosynthesis of androstenedione into estrone, and the biosynthesis of testosterone to estradiol. Estrogens include the broad range of aromatized hormones created form androgens. The specific attribute of estrogens that separate them from progestogens, androgens and corticoids is that estrogens are the only aromatized steroid hormones. Estradiol, the most potent endogenous estrogen, is biosynthesized by aromatization from androgens by aromatase (which is also called estrogen synthase).
    [Show full text]
  • Test Report Comprehensive Hormone Insights™
    698814 COMPREHENSIVE HORMONE INSIGHTS™ TEST REPORT Dr. Maximus, N.D. E: [email protected] Date of Collection: P: 403-241-4500 Time of Collection: F: 403-241-4501 Date of Receipt: www.rmalab.com Reported On: CHI Accession: 698814 Healthcare Professional Patient Age: Dr. Maximus, N.D. Date of Birth: Gender: Male F: Relevant Medications Biometrics Curcumin Height (in) : 73 Weight (lb) : 180 BMI : 24 Waist (in) : 35 Hip (in) : 41 CHI Accession: 698814 SUMMARY HMUS01 How to read the graphs LEGEND: 50 66 Sex Steroid Hormones 50 66 Middle third of 33 33 84 reference population Hormone Start of 83 100 80 100 highest 16 Percentile Precursors 16 Percentile third of Sum of Androgens Sum of Estrogens 50 66 reference 0 0 population (T, DHT, α+β androstanediol) Listed in Interp Guide 33 84 End of 100 16 lowest Percentile00 50 66 50 66 third of 33 33 84 reference 0 population Patient’s percentile rank 81 100 95 100 compared to reference 16 Percentile 16 Percentile population (see summary) DHEA + Metabolites Sum of Progesterone Metabolites 0 (DHEA + A + E) 0 α+β Pregnanediol Cortisol Melatonin Oxidative Stress Free Cortisol Profile (ng/mg) 100 50 66 50 66 33 84 33 84 80 64 100 0 100 16 Percentile 16 Percentile 60 6-sulfatoxy 8-Hydroxy-2- 0 Melatonin 0 deoxyguanosine 40 (Overnight) (Overnight) 20 6-sulfatoxymelatonin provides 8-hydroxy-2-deoxyguanosine is Cortisol/Creatinine (ng/mg) insight into melatonin levels. a marker of oxidative stress 0 Morning Dinner Bedtime A B C 50 66 Free cortisol Cortisol Metabolites 33 84 profile is used to provides a general Testosterone Cortisol assess diurnal assessment of 16 100 cortisol rhythm adrenal cortisol 16 Percentile Cortisol production Cortisol Metabolites 0 (α+β THF + THE) Testosterone Cortisol/Testosterone provides insight into relative catabolic (cortisol) and anabolic (testosterone) states.
    [Show full text]
  • 2018 Apigenin Male Infertility (2).Pdf
    Original Article Thai Journal of Pharmaceutical Sciences Apigenin and baicalin, each alone or in low-dose combination, attenuated chloroquine induced male infertility in adult rats Amira Akilah, Mohamed Balaha*, Mohamed-Nabeih Abd-El Rahman, Sabiha Hedya Department of Pharmacology, Faculty of Medicine, Tanta University, Postal No. 31527, El-Gish Street, Tanta, Egypt Corresponding Author: Department of Pharmacology, ABSTRACT Faculty of Medicine, Tanta University, Postal No. 31527, Introduction: Male infertility is a worldwide health problem, which accounts for about 50% of all El-Gish Street, Tanta, Egypt. cases of infertility and considered as the most common single defined cause of infertility. Recently, Tel.: +201284451952. E-mail: apigenin and baicalin exhibited a powerful antioxidant and antiapoptotic activities. Consequently, in [email protected]. the present study, we evaluated the possible protective effect of apigenin and baicalin, either alone or Edu.Eg (M. Balaha). in low-dose combination, on a rat model of male infertility, regarding for its effects on the hormonal assay, testicular weight, sperm parameters, oxidative-stress state, apoptosis, and histopathological Received: Mar 06, 2018 changes. Material and methods: 12-week-old adult male Wister rats received 10 mg/kg/d Accepted: May 08, 2018 chloroquine orally for 30 days to induce male infertility. Either apigenin (30 or 15 mg/kg/d), baicalin Published: July 10, 2018 (100 or 50 mg/kg/d) or a combination of 15 mg/kg/d apigenin and 50 mg/kg/d baicalin received daily
    [Show full text]
  • In Vivo Effect of PC-SPES on Prostate Growth and Hepatic CYP3A Expression in Rats
    JPET Fast Forward. Published on April 3, 2003 as DOI: 10.1124/jpet.102.048645 JPETThis Fast article Forward. has not been Published copyedited and on formatted. April 3, The 2003 final asversion DOI:10.1124/jpet.102.048645 may differ from this version. JPET #48645 In Vivo Effect of PC-SPES on Prostate Growth and Hepatic CYP3A Expression in Rats Teri Wadsworth, Hataya Poonyagariyagorn, Elinore Sullivan, Dennis Koop and Charles E. Roselli. Downloaded from Department of Physiology and Pharmacology Oregon Health & Science University, Portland, OR. jpet.aspetjournals.org at ASPET Journals on September 26, 2021 1 Copyright 2003 by the American Society for Pharmacology and Experimental Therapeutics. JPET Fast Forward. Published on April 3, 2003 as DOI: 10.1124/jpet.102.048645 This article has not been copyedited and formatted. The final version may differ from this version. JPET #48645 Running Title: In vivo effects of PC-SPES Correspondence: Dr. Charles E. Roselli, Department of Physiology and Pharmacology L334, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098, Tel (503) 494-5837, FAX (503) 494-4352, email: [email protected] Number of text pages: 20 number of tables: 4 Downloaded from number of figures: 4 number of references: 40 jpet.aspetjournals.org number of words in the Abstract: 250 number of words the Introduction: 748 number of words in the Discussion: 1478 at ASPET Journals on September 26, 2021 nonstandard abbreviations: National Institute of Diabetes and Digestive and Kidney Disease (NIDDK);
    [Show full text]
  • (Apigenin, Luteolin, Chrysin) and Their Importance for Health
    Mellifera 2020, 20(1):16-27 MELLIFERA REVIEW ARTICLE Flavones (Apigenin, Luteolin, Chrysin) and Their Importance for Health Fatma Özsel ÖZCAN1*, Ozan ALDEMİR2, Bülent KARABULUT3 1Beykoz Üniversity, Faculty of Art and Design, Department of Gastronomy and Culinary Arts, İstanbul, Turkey 2Ege University Faculty of Medicine, Department of Biochemistry, İzmir, TURKEY 3Ege University Faculty of Medicine, Department of Oncology, İzmir, TURKEY * Corresponding author e-mail: [email protected] Received: 14th March, 2020; accepted: 4th May, 2020; published: 29th June, 2020 A B S T R A C T It has been shown in recent years that foods called functional foods may protect against certain types of cancer, cardiovascular diseases and cognitive dysfunctions. In the studies performed, the flavonoids (apigenin, chrysin, luteolin) which are subclass of flavonoids have been shown to have antioxidant, antiinflammatory, antiallergic, neuroprotective and cardioprotective effects and it is presented as the current treatment method in the treatment of some diseases. The structure function, nutritional resources and potential therapeutic properties of the flavones, which are also used as supplement in the compost, have been studied. The purpose of this review is to evaluate the therapeutic effects of flavones in certain diseases. The positive effect of 16 flavones on health can be proven in many experimental studies and can be proven in the long run. Keywords: Functional nutrients, flavones, apigenin, luteolin, chrysin Introduction Polyphenolic flavonoids are among the affected by factors such as plant species, wide variety of phytochemicals found in the environment, genetics, light, maturity, human diet. Current studies reveal that harvest [3]. Flavones, a subset of dietary flavonoids are inversely related to flavonoids, form glycosylation and contain many cancers and age-related diseases [1].
    [Show full text]
  • SNI May-Jun-2011 Cover Final
    OPEN ACCESS Editor-in-Chief: Surgical Neurology International James I. Ausman, MD, PhD For entire Editorial Board visit : University of California, Los http://www.surgicalneurologyint.com Angeles, CA, USA Review Article Stuck at the bench: Potential natural neuroprotective compounds for concussion Anthony L. Petraglia, Ethan A. Winkler1, Julian E. Bailes2 Department of Neurosurgery, University of Rochester Medical Center, Rochester, NY, 1University of Rochester School of Medicine and Dentistry, Rochester, NY, 2Department of Neurosurgery, North Shore University Health System, Evanston, IL, USA E-mail: *Anthony L. Petraglia - [email protected]; Ethan A. Winkler - [email protected]; Julian E. Bailes - [email protected] *Corresponding author Received: 29 August 11 Accepted: 22 September 11 Published: 12 October 11 This article may be cited as: Petraglia AL, Winkler EA, Bailes JE. Stuck at the bench: Potential natural neuroprotective compounds for concussion. Surg Neurol Int 2011;2:146. Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2011/2/1/146/85987 Copyright: © 2011 Petraglia AL. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Background: While numerous laboratory studies have searched for neuroprotective treatment approaches to traumatic brain injury, no therapies have successfully translated from the bench to the bedside. Concussion is a unique form of brain injury, in that the current mainstay of treatment focuses on both physical and cognitive rest. Treatments for concussion are lacking. The concept of neuro-prophylactic compounds or supplements is also an intriguing one, especially as we are learning more about the relationship of numerous sub-concussive blows and/or repetitive concussive impacts and the development of chronic neurodegenerative disease.
    [Show full text]
  • Selection of Effective Cocrystals Former for Dissolution Rate Improvement Of
    Selection of effective cocrystals former for dissolution rate improvement of active pharmaceutical ingredients based on lipoaffinity index Piotr Cysewski, Maciej Przybylek To cite this version: Piotr Cysewski, Maciej Przybylek. Selection of effective cocrystals former for dissolution rate im- provement of active pharmaceutical ingredients based on lipoaffinity index. European Journal of Pharmaceutical Sciences, Elsevier, 2017, 107, pp.87-96. 10.1016/j.ejps.2017.07.004. hal-01773096 HAL Id: hal-01773096 https://hal.archives-ouvertes.fr/hal-01773096 Submitted on 29 Apr 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Accepted Manuscript Selection of effective cocrystals former for dissolution rate improvement of active pharmaceutical ingredients based on lipoaffinity index Piotr Cysewski, Maciej Przybyłek PII: S0928-0987(17)30403-7 DOI: doi: 10.1016/j.ejps.2017.07.004 Reference: PHASCI 4127 To appear in: European Journal of Pharmaceutical Sciences Received date: 11 April 2017 Revised date: 6 June 2017 Accepted date: 3 July 2017 Please cite this article as: Piotr Cysewski, Maciej Przybyłek , Selection of effective cocrystals former for dissolution rate improvement of active pharmaceutical ingredients based on lipoaffinity index, European Journal of Pharmaceutical Sciences (2017), doi: 10.1016/j.ejps.2017.07.004 This is a PDF file of an unedited manuscript that has been accepted for publication.
    [Show full text]
  • Inhibitory Effect of Acacetin, Apigenin, Chrysin and Pinocembrin on Human Cytochrome P450 3A4
    ORIGINAL SCIENTIFIC PAPER Croat. Chem. Acta 2020, 93(1), 33–39 Published online: August 03, 2020 DOI: 10.5562/cca3652 Inhibitory Effect of Acacetin, Apigenin, Chrysin and Pinocembrin on Human Cytochrome P450 3A4 Martin Kondža,1 Hrvoje Rimac,2,3 Željan Maleš,4 Petra Turčić,5 Ivan Ćavar,6 Mirza Bojić2,* 1 University of Mostar, Faculty of Pharmacy, Matice hrvatske bb, 88000 Mostar, Bosnia and Herzegovina 2 University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, A. Kovačića 1, 10000 Zagreb, Croatia 3 South Ural State University, Higher Medical and Biological School, Laboratory of Computational Modeling of Drugs, 454000 Chelyabinsk, Russian Federation 4 University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Botany, Schrottova 39, 10000 Zagreb, Croatia 5 University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmacology, Domagojeva 2, 10000 Zagreb, Croatia 6 University of Mostar, Faculty of Medicine, Kralja Petra Krešimira IV bb, 88000 Mostar, Bosnia and Herzegovina * Corresponding author’s e-mail address: [email protected] RECEIVED: June 26, 2020 REVISED: July 28, 2020 ACCEPTED: July 30, 2020 Abstract: Cytochrome P450 3A4 is the most significant enzyme in metabolism of medications. Flavonoids are common secondary plant metabolites found in fruits and vegetables. Some flavonoids can interact with other drugs by inhibiting cytochrome P450 enzymes. Thus, the objective of this study was to determine inhibition kinetics of cytochrome P450 3A4 by flavonoids: acacetin, apigenin, chrysin and pinocembrin. For this purpose, testosterone was used as marker substrate, and generation of the 6β-hydroxy metabolite was monitored by high performance liquid chromatography coupled with diode array detector.
    [Show full text]
  • Cphi & P-MEC China Exhibition List展商名单version版本20180116
    CPhI & P-MEC China Exhibition List展商名单 Version版本 20180116 Booth/ Company Name/公司中英文名 Product/产品 展位号 Carbosynth Ltd E1A01 Toronto Research Chemicals Inc E1A08 SiliCycle Inc. E1A10 SA TOURNAIRE E1A11 Indena SpA E1A17 Trifarma E1A21 LLC Velpharma E1A25 Anuh Pharma E1A31 Chemclone Industries E1A51 Hetero Labs Limited E1B09 Concord Biotech Limited E1B10 ScinoPharm Taiwan Ltd E1B11 Dongkook Pharmaceutical Co., Ltd. E1B19 Shenzhen Salubris Pharmaceuticals Co., Ltd E1B22 GfM mbH E1B25 Leawell International Ltd E1B28 DCS Pharma AG E1B31 Agno Pharma E1B32 Newchem Spa E1B35 APEX HEALTHCARE LIMITED E1B51 AMRI E1C21 Aarti Drugs Limited E1C25 Espee Group Innovators E1C31 Ruland Chemical Co., Ltd. E1C32 Merck Chemicals (Shanghai) Co., Ltd. E1C51 Mediking Pharmaceutical Group Ltd E1C57 珠海联邦制药股份有限公司/The United E1D01 Laboratories International Holdings Ltd. FMC Corporation E1D02 Kingchem (Liaoning) Chemical Co., Ltd E1D10 Doosan Corporation E1D22 Sunasia Co., Ltd. E1D25 Bolon Pharmachem Co., Ltd. E1D26 Savior Lifetec Corporation E1D27 Alchem International Pvt Ltd E1D31 Polish Investment and Trade Agency E1D57 Fischer Chemicals AG E1E01 NGL Fine Chem Limited E1E24 常州艾柯轧辊有限公司/ECCO Roller E1E25 Linnea SA E1E26 Everlight Chemical Industrial Corporation E1E27 HARMAN FINOCHEM E1E28 Zhechem Co Ltd E1F01 Midas Pharma GmbH Shanghai Representativ E1F03 Supriya Lifescience Ltd E1F10 KOA Shoji Co Ltd E1F22 NOF Corporation E1F24 上海贺利氏工业技术材料有限公司/Heraeus E1F26 Materials Technology Shanghai Ltd. Novacyl Asia Pacific Ltd E1F28 PharmSol Europe Limited E1F32 Bachem AG E1F35 Louston International Inc. E1F51 High Science Co Ltd E1F55 Chemsphere Technology Inc. E1F57a PharmaCore Biotech Co., Ltd. E1F57b Rockwood Lithium GmbH E1G51 Sarv Bio Labs Pvt Ltd E1G57 抗病毒类、抗肿瘤类、抗感染类和甾体类中间体、原料药和药物制剂及医药合约研发和加工服务 上海创诺医药集团有限公司/Shanghai Desano APIs and Finished products of ARV, Oncology, Anti-infection and Hormone drugs and E1H01 Pharmaceuticals Co., Ltd.
    [Show full text]
  • Characterization of the CYP3A4 Enzyme Inhibition Potential of Selected Flavonoids
    Article Characterization of the CYP3A4 Enzyme Inhibition Potential of Selected Flavonoids Martin Kondža 1 , Mirza Boji´c 2,* , Ivona Tomi´c 1, Željan Maleš 2 , Valentina Rezi´c 3 and Ivan Cavar´ 4 1 Faculty of Pharmacy, University of Mostar, Matice Hrvatske bb, 88000 Mostar, Bosnia and Herzegovina; [email protected] (M.K.); [email protected] (I.T.) 2 University of Zagreb Faculty of Pharmacy and Biochemistry, Ante Kovaˇci´ca1, 10000 Zagreb, Croatia; [email protected] 3 Farmavita d.o.o., Igmanska 5A, 71000 Sarajevo, Bosnia and Herzegovina; [email protected] 4 Faculty of Medicine, University of Mostar, Zrinskog Frankopana 34, 88000 Mostar, Bosnia and Herzegovina; [email protected] * Correspondence: [email protected]; Tel.: +385-1-4818-304 Abstract: Acacetin, apigenin, chrysin, and pinocembrin are flavonoid aglycones found in foods such as parsley, honey, celery, and chamomile tea. Flavonoids can act as substrates and inhibitors of the CYP3A4 enzyme, a heme containing enzyme responsible for the metabolism of one third of drugs on the market. The aim of this study was to investigate the inhibitory effect of selected flavonoids on the CYP3A4 enzyme, the kinetics of inhibition, the possible covalent binding of the inhibitor to the enzyme, and whether flavonoids can act as pseudo-irreversible inhibitors. For the determination of inhibition kinetics, nifedipine oxidation was used as a marker reaction. A hemochromopyridine test was used to assess the possible covalent binding to the heme, and incubation with dialysis was used in order to assess the reversibility of the inhibition.
    [Show full text]
  • Natural Compounds to Counteract Testosterone Depletion in Aging
    s & H oid orm er o t n S f a Rojas and Pandey, J Steroids Horm Sci 2014, 5:1 l o S l c a i Journal of DOI: 10.4172/2157-7536.1000e112 n e r n u c o e J ISSN: 2157-7536 Steroids & Hormonal Science Editorial Open Access Natural Compounds to Counteract Testosterone Depletion in Aging Daniela P Rojas and Akhilesh K Pandey* Garrison Institute on Aging, Department of Neurology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA Aging is accompanied by many biological and physiological been seen that mutations in StAR protein result in sometimes lethal changes in the body, including the depletion of sex hormones such condition called, congenital lipoid adrenal hyperplasia, which involves as testosterone. Testosterone is an important sex hormone for many a blockage in the synthesis of steroid hormones, again expressing the physiological and biological functions in the body, and depletion of it importance of StAR protein function to produce testosterone [7]. StAR may cause changes that can be negative to the normal functioning of protein is expressed via a response to trophic hormone and it is cAMP- the body. Aging is associated with a gradual depletion of testosterone of mediated [8]. about 2-3% annually, starting from the age of 30 [1]. This depletion of With this information, one can conclude that aging is related the sex hormones has many implications in the physiological functions to a decrease in the levels of StAR protein and, thus, a decrease in in the body, such as effects in muscle mass, liver function and immune testosterone biosynthesis.
    [Show full text]
  • Apigenin 520-36-5
    SUMMARY OF DATA FOR CHEMICAL SELECTION Apigenin 520-36-5 BASIS OF NOMINATION TO THE CSWG Apigenin is brought to the attention of the CSWG because of a recent scientific article citing this flavonoid as a substance that can be metabolically activated to produce toxic prooxidant phenoxyl radicals. Pure apigenin is used primarily in research as a protein kinase inhibitor that may suppress tumor promotion and that has anti-proliferating effects on human breast cancer cells and inhibitory actions on MAP kinase. Apigenin is also one of several active ingredients in the popular herbal remedy, chamomile. Apigenin is found naturally in many fruits and vegetables, including apples and celery. It is found in several popular spices, including basil, oregano, tarragon, cilantro, and parsley. As a representative of flavonoids containing phenol B rings that may induce lipid peroxidation, apigenin is a candidate for testing. SELECTION STATUS ACTION BY CSWG: 12/12/00 Studies requested: Developmental toxicity Short-term tests for chromosomal aberrations Priority: None assigned Rationale/Remarks: Nomination based on concerns about apigenin’s potential to produce possibly toxic radicals and its estrogenic activity NCI will conduct a mouse lymphoma assay Apigenin 520-36-5 CHEMICAL IDENTIFICATION CAS Registry Number: 520-36-5 Chemical Abstracts Service Name: 4H-1-benzopyran-4-one,5,7-dihydroxy-2-(4- hydroxy-phenyl)- (9CI) Synonyms and Trade Names: Apigenin; apigenine; apigenol; chamomile; C.I. natural yellow 1; 2-(p-hydroxyphenyl)-5,7- dihydroxy-chromone; spigenin; 4',5,7- trihydroxyflavone Structural Class: Flavone Structure, Molecular Formula and Molecular Weight: OH HO O OH O C15H10O5 Mol.
    [Show full text]